Indian anti-diabetic pharma market is largely driven by huge diabetic patient base, finds Netscribes

Netscribes (India) Pvt. Ltd., launches a report on the Anti-Diabetic Pharmaceuticals Market in India 2012 as part of Netscribes’ Healthcare Industry report series
By: Netscribes
 
March 30, 2012 - PRLog -- Netscribes (India) Pvt. Ltd., a knowledge consulting solutions company, announces the launch of its Anti-Diabetic Pharmaceuticals Market in India 2012 report. India being the second largest diabetic pool in the world, the market is expected to show steady growth in the coming years.

The report begins with the introduction section which offers a brief classification of the different types of diabetes. It then gives a classification of the diabetes market, and then provides a brief description of different classes of diabetes pharmaceuticals. The market overview section provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth. It also provides a global diabetes map.

An analysis of the drivers explains the factors for growth of the industry including increasing diabetes cases, introduction of newer and better drugs, increasing aging population and increase in health insurance policies. The key challenges include price regulation in the insulin market, competition from use of complementary and alternative medicines and maintainence of a healthy lifestyle to avoid diabetes.

The Government initiatives section gives a brief description of the different diabetes programmes undertaken by the Government.

A brief overview of the drug regulations and patents is presented in the next section. It focuses the different stages of clinical trial that a drug must pass through. Drug regulations in India and drugs approved for marketing have been provided. The section also provides a list of important patent approvals for diabetes drugs.

The competition section gives overview of pharmaceutical companies in the country operating in the anti diabetic pharmaceutical and insulin segments along with segmentation of players in respect to production of oral drugs and insulin. Thereafter, the report highlights the features of the major players operating in the market in detail. It includes elaborate profile of the major players in the market along with their financial analysis. Porters Five Forces Analysis has been incorporated for a brief but effective understanding of the market scenario.

The strategic recommendations section focuses on some effective strategic decisions which can be taken up by companies to increase their market shares.

For more details on the content of each report and ordering information please contact:
Tamojit Roy
Email: sales@netscribes.com

About Netscribes (India) Pvt. Ltd.

Netscribes (www.netscribes.com) is a pioneering knowledge consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, publishing services and customized knowledge database creation. At its core lies a true value proposition that draws upon a vast knowledge base.

For more information please write to info@netscribes.com
End
Source:Netscribes
Email:***@netscribes.com Email Verified
Zip:400012
Tags:Type I Diabetes, Type Ii Diabetes, Gestational Diabetes, Oral Drugs, Insulin, Anti-diabetic Pharmaceuticals, Glucotrol
Industry:Health, Research
Location:Mumbai - Maharashtra - India
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Netscribes Data and Insights News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share